Timothy W. Synold

MedicineBiochemistry, Genetics and Molecular BiologyChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 24 papers. Top paper: “Peritransplantation ruxolitinib administration is safe and effective in patients with myelofibrosis: a pilot open-label study”.

Peritransplantation ruxolitinib administration is safe and effective in patients with myelofibrosis: a pilot open-label study

Blood Advances(2021)10.1182/bloodadvances.2021005035

N/A

1.4DataRank · unranked

45 citations

Ni‐Chun Tsai, Timothy W. Synold, Sally Mokhtari, Weimin Tsia, Joycelynne Palmer +14 more

Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial

The Lancet(2023)10.1016/s0140-6736(23)00913-3

N/A

1.4DataRank · unranked

49 citations

Catherine M. Tangen, Elisabeth I. Heath, Mark N. Stein, Maxwell V. Meng, Ajjai Alva +14 more

Reduction of myeloid‐derived suppressor cells in prostate cancer murine models and patients following white button mushroom treatment

Clinical and Translational Medicine(2024)10.1002/ctm2.70048

N/A

0.457DataRank · unranked

12 citations

Shoubao Ma, Przemyslaw Twardowski, Clayton Lau, Yin Chan, Kelly Wong +12 more

An LC–MS/MS Method for Simultaneous Determination of LB-100 and Its Active Metabolite, Endothall, in Human Plasma

Bioanalysis(2023)10.4155/bio-2023-0078

N/A

0.104DataRank · unranked

1 citations

Erminia Massarelli, Eric Forman, John S. Kovach, Ravi Salgia, Timothy W. Synold +1 more

An LC–MS/MS method for determination of the bromodomain inhibitor ZEN-3694 and its metabolite ZEN-3791 in human plasma

Bioanalysis(2024)10.4155/bio-2023-0252

N/A

0.104DataRank · unranked

1 citations

Haider Mahdi, Richard Piekarz, Jan H. Beumer, Timothy W. Synold, Ye Feng

Off-the-shelf, steroid-resistant, IL13Rα2-specific CAR T cells for treatment of glioblastoma

Neuro-Oncology(2022)10.1093/neuonc/noac024

N/A

0DataRank · unranked

144 citations

Analiz Rodriguez, Joycelynne Palmer, Julie R. Ostberg, Araceli Naranjo, Jamie R. Wagner +18 more

EVEREST: Everolimus for renal cancer ensuing surgical therapy—A phase III study (SWOG S0931, NCT01120249).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.17_suppl.lba4500

N/A

0DataRank · unranked

39 citations

Catherine M. Tangen, Elisabeth I. Heath, Mark N. Stein, Maxwell V. Meng, Ajjai Alva +15 more

Phase Ib trial of erdafitinib (E) combined with enfortumab vedotin (EV) following platinum and PD-1/L1 inhibitors for metastatic urothelial carcinoma (mUC) with FGFR2/3 genetic alterations (GAs).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.tps595

N/A

0DataRank · unranked

12 citations

Youngchul Kim, Jennifer Rembisz, Richard Piekarz, Timothy W. Synold, Jingsong Zhang +2 more

Pharmacokinetics of Sustained-release Buprenorphine and Extended-release Buprenorphine in Mice with Surgical Catheterization

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.14.484329

N/A

0DataRank · unranked

0 citations

Elizabeth Bloom‐Saldana, Timothy W. Synold, Richard W. Ermel, Patrick T. Fueger, James Finlay +1 more

Small molecule targeting of transcription-replication conflict for selective chemotherapy

Cell chemical biology(2023)10.1016/j.chembiol.2023.07.001

N/A

0DataRank · unranked

56 citations

Min Li, Caroline M. Li, Pouya Haratipour, Robert Lingeman, Jennifer Jossart +17 more

Mechanism-Driven and Clinically Focused Development of Botanical Foods as Multitarget Anticancer Medicine: Collective Perspectives and Insights from Preclinical Studies, IND Applications and Early-Phase Clinical Trials

Cancers(2023)10.3390/cancers15030701

N/A

0DataRank · unranked

18 citations

Yin Chan, Kelly Wong, Ryohei Yoshitake, David Sadava, Timothy W. Synold +5 more

Cell facilitation promotes growth and survival under drug pressure in breast cancer

Nature Communications(2023)10.1038/s41467-023-39242-6

N/A

0DataRank · unranked

29 citations

Jason I. Griffiths, Vince Kornél Grolmusz, Aritro Nath, Jinfeng Chen, Eric F. Medina +5 more

A phase 1 trial of 8‐chloro‐adenosine in relapsed/refractory acute myeloid leukemia: An evaluation of safety and pharmacokinetics

Cancer(2023)10.1002/cncr.35077

N/A

0DataRank · unranked

5 citations

Lisa S. Chen, Joycelynne Palmer, Jianying Zhang, Timothy W. Synold, Ralf Buettner +8 more

Leflunomide Confers Rapid Recovery from COVID-19 and is Coupled with Temporal Immunologic Changes

Journal of Immunological Sciences(2023)10.29245/2578-3009/2023/1.1241

N/A

0DataRank · unranked

1 citations

James F. Sanchez, Joycelynne Palmer, Timothy W. Synold, Flavia Chiuppesi, Sandra P. Thomas +11 more

A phase 1 trial of umbilical cord blood–derived tumor-reactive PD-L1+ natural killer cells engineered to express soluble IL-15 (TRACK-NK) in patients with non–small-cell lung cancer (NSCLC) refractory to PD-1/PD-L1 inhibitors.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps2665

N/A

0DataRank · unranked

4 citations

Stephen J. Forman, Joycelynne Palmer, Timothy W. Synold, Lei Tian, Ting Lu +14 more

Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial

European Urology(2024)10.1016/j.eururo.2024.05.012

N/A

0DataRank · unranked

8 citations

Catherine M. Tangen, Elisabeth I. Heath, Shuchi Gulati, Mark N. Stein, Maxwell V. Meng +16 more

Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients with Ovarian Cancer with Peritoneal Metastases: A Multicenter US Phase I Trial

Annals of Surgical Oncology(2025)10.1245/s10434-025-18432-0

N/A

0DataRank · unranked

4 citations

Rosemary Senguttuvan, Nora Ruel, Paul Frankel, Susan E. Yost, Sarah Cole +16 more

Cell-selective telomere damage by thiopurine-based oligonucleotide for diffuse large B cell lymphoma immunotherapy

Molecular Therapy(2025)10.1016/j.ymthe.2025.07.029

N/A

0DataRank · unranked

0 citations

Elaine Kang, Dongfang Wang, Yong Liang, Piotr Swiderski, Feng Ye +6 more

In vivo anticancer activity of a rhodium metalloinsertor in the HCT116 xenograft tumor model

Proceedings of the National Academy of Sciences(2020)10.1073/pnas.2006569117

N/A

0DataRank · unranked

26 citations

Timothy W. Synold, Jun Wu, Jacqueline K. Barton, Stephanie D. Threatt

Pre-clinical evaluation of a potent and effective Pin1-degrading agent in pancreatic cancer

Molecular Therapy Oncology(2025)10.1016/j.omton.2025.201078

N/A

0DataRank · unranked

0 citations

Tiane Li, A.M. PRENTISS, Parima Udompholkul, Fan Xia, Timothy W. Synold +5 more

Toxicities Associated With Metformin/Ritonavir Combination Treatment in Relapsed/Refractory Multiple Myeloma

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2020.05.017

N/A

0DataRank · unranked

7 citations

Joycelynne Palmer, Timothy W. Synold, Behrouz Salehian, Michael Rosenzweig, James F. Sanchez +12 more

Systemic Anti–PD-1 Immunotherapy Results in PD-1 Blockade on T Cells in the Cerebrospinal Fluid

JAMA Oncology(2020)10.1001/jamaoncol.2020.4508

N/A

0DataRank · unranked

45 citations

Dongrui Wang, M. Suzette Blanchard, Vivi Tran, Darya Alizadeh, Renate Starr +10 more

Phase I study of TRC102 in combination with cisplatin and pemetrexed in patients with advanced solid tumors/Phase II study of TRC102 with pemetrexed in patients with mesothelioma refractory to pemetrexed and cisplatin or carboplatin.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9055

N/A

0DataRank · unranked

1 citations

Paul Frankel, Jonathan W. Riess, Anthony B. El-Khoueiry, Liza C. Villaruz, Stephen Leong +5 more

Development and validation of an LC–MS/MS generic assay platform for small molecule drug bioanalysis

Journal of Pharmaceutical and Biomedical Analysis(2021)10.1016/j.jpba.2021.114185

N/A

0DataRank · unranked

7 citations

Joseph M. Covey, Melinda G. Hollingshead, Apurva K. Srivastava, Timothy W. Synold, Jan H. Beumer +1 more